Bruker (BRKR) Stock Price, News & Analysis

Company Overview

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Key Stats

• Today's Range: $37.92 to $39.25
• 50-Day Range: $35.98 to $52.92
• 52-Week Range: $34.10 to $82.04
• Volume: 1.65 million shs
• Average Volume: 1.52 million shs
• Market Capitalization: $5.92 billion
• P/E Ratio: 51.41
• Dividend Yield: 0.51%
• Price Target: $65.00
• Consensus Rating: Moderate Buy

Bruker Stock Analysis - MarketRank™

Bruker scored higher than 100% of companies evaluated by MarketBeat, and ranked 81st out of 654 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Bruker has received a consensus rating of Moderate Buy. The company's average rating score is 2.55, and is based on 6 buy ratings, 5 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Bruker has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 17.10%

Earnings Growth

Earnings for Bruker are expected to grow by 17.10% in the coming year, from $2.69 to $3.15 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Bruker is 51.41, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.71.

Price to Earnings Ratio vs. Sector

The P/E ratio of Bruker is 51.41, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 42.07.

Price to Earnings Growth Ratio

Bruker has a PEG Ratio of 2.16. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Bruker has a P/B Ratio of 3.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

6.30% of the float of Bruker has been sold short.

Short Interest Ratio / Days to Cover

Bruker has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Bruker has recently decreased by 24.03%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Bruker has a dividend yield of 0.55%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Bruker does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Bruker is 26.32%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Bruker will have a dividend payout ratio of 6.35% next year. This indicates that Bruker will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.8 / 5
• Environmental Score: -1.48

Percentage of Shares Shorted

6.30% of the float of Bruker has been sold short.

Short Interest Ratio / Days to Cover

Bruker has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Bruker has recently decreased by 24.03%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.13

News Sentiment

Bruker has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 19 news articles for Bruker this week, compared to 9 articles on an average week.

Search Interest

6 people have searched for BRKR on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Bruker to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

Company Ownership

• Score: 5.0 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Bruker insiders have bought more of their company's stock than they have sold. Specifically, they have bought $23,700.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

27.30% of the stock of Bruker is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

79.52% of the stock of Bruker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

BRKR Stock Analysis - Frequently Asked Questions

How have BRKR shares performed this year?

Bruker's stock was trading at $58.62 at the beginning of the year. Since then, BRKR stock has decreased by 33.4% and is now trading at $39.07.
View the best growth stocks for 2025 here.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) announced its earnings results on Thursday, February, 13th. The medical research company reported $0.76 EPS for the quarter, topping analysts' consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a trailing twelve-month return on equity of 21.01%.
Read the conference call transcript.

Does Bruker have any subsidiaries?

Bruker subsidiaries include these companies: PMOD Technologies, Arxspan, Alicona Imaging, JPK In­stru­ments, Luxendo, Hysitron, InVivo Biotech Services GmbH, and others.

Who are Bruker's major shareholders?

Top institutional shareholders of Bruker include Pallas Capital Advisors LLC (6.26%), Vaughan Nelson Investment Management L.P. (0.50%), Rhumbline Advisers (0.21%) and Allspring Global Investments Holdings LLC (0.14%). Insiders that own company stock include Frank H Laukien, Richard A Packer, Gerald N Herman, Hermann Fritz Requardt, Cynthia M Friend and Thomas Bures.
View institutional ownership trends.

How do I buy shares of Bruker?

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bruker investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

• Last Earnings: 2/13/2025
• Record date for 3/28 Dividend: 3/17/2025
• Ex-Dividend for 3/28 Dividend: 3/17/2025
• Dividend Payable: 3/28/2025
• Today: 4/27/2025
• Next Earnings (Estimated): 5/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Analytical instruments
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:BRKR
• CIK: 1109354
• Web: www.bruker.com
• Phone: (978) 663-3660
• Fax: 978-663-5585
• Employees: 8,520
• Year Founded: 1960

Price Target and Rating

• Average Stock Price Target: $65.00
• High Stock Price Target: $85.00
• Low Stock Price Target: $50.00
• Potential Upside/Downside: +66.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.55
• Research Coverage: 11 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.76
• Trailing P/E Ratio: 51.41
• Forward P/E Ratio: 14.52
• P/E Growth: 2.16
• Net Income: $113.10 million
• Net Margins: 3.36%
• Pretax Margin: 6.15%
• Return on Equity: 21.01%
• Return on Assets: 6.46%

Debt

• Debt-to-Equity Ratio: 1.15
• Current Ratio: 1.60
• Quick Ratio: 0.77

Sales & Book Value

• Annual Sales: $3.37 billion
• Price / Sales: 1.76
• Cash Flow: $2.65 per share
• Price / Cash Flow: 14.74
• Book Value: $11.85 per share
• Price / Book: 3.30

Miscellaneous

• Outstanding Shares: 151,521,000
• Free Float: 108,696,000
• Market Cap: $5.92 billion
• Optionable: Optionable
• Beta: 1.18